Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOFOSBUVIR\VELPATASVIR: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

42.5%
Female
57.5%
Male

Age Information

The average age of patients reporting adverse events with SOFOSBUVIR\VELPATASVIR is 54.5 years.

Geographic Distribution

The majority of adverse event reports for SOFOSBUVIR\VELPATASVIR originate from US.

Report Summary & Outcomes

18,042
Total Reports
18,042
As Primary/Secondary Suspect
978
Deaths Reported
2,342
Hospitalizations
143
Life-Threatening
289
Disabilities

Reporting Timeline

First adverse event report: 1985. Most recent report: 20250912. View full timeline →

More About SOFOSBUVIR\VELPATASVIR

SOFOSBUVIR\VELPATASVIR Full Profile Reports by Year Drug Interactions